Medical Microbiology articles for Australia

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 55

Article ‘Count’ for Medical Microbiology.

Journal Count Share
1 0.13
Biodegradable Nanospray for Sunlight-Activated Photodynamic Antibacterial Therapy and Wound Healing 0.13
1 0.10
Extensive cross-species transmission of pathogens and antibiotic resistance genes in mammals neglected by public health surveillance 0.10
1 0.05
Naturally acquired promoter variation influences Streptococcus pneumoniae infection outcomes 0.05
5 2.62
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial 0.02
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18–49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years 0.10
Current Epidemiology and Infection Characteristics of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand 0.90
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial 1.00
Kinetics and Predictors of Hepatitis B Surface Antigen (HBsAg) Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection 0.60
1 0.06
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions 0.06
1 0.84
P selectin promotes SARS-CoV-2 interactions with platelets and the endothelium 0.84
1 0.07
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program 0.07
5 3.00
The Pandemic REspiratory Virus Epidemiological SurveillaNce Trial - A self-swab surveillance system for respiratory viruses nested within FluTracking 1.00
Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B 1.00
Extreme Genetic Diversity and Signatures of Balancing Selection in Plasmodium vivax Blood-Stage Antigens 0.86
Tuberculosis Disease Prevalence Among People Who Smoke Illicit Drugs: A Respondent- Driven Sampling Study in the Western Cape, South Africa 0.02
Impact of Puberty on Immune Responses to iMycobacterium tuberculosis/i in South African Adolescents 0.13
2 0.29
Natural maternal immunity protects neonates from sepsis 0.27
In vivo screen of Plasmodium targets for mosquito-based malaria control 0.02
26 6.47
Spatial transcriptomic atlas of murine neurotoxocariasis reveals region-specific host responses and dysfunction in the brain 0.15
GID/CTLH E3 ligase complex control cell fate programs for sexual development of Plasmodium falciparum 1.00
Potent acridone antimalarial against all three life stages of Plasmodium 0.05
Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum 0.03
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosis 0.67
PTRAMP, CSS and Ripr form a conserved complex required for merozoite invasion of species into erythrocytes 0.63
Efficacy of two rounds of albendazole treatment on soil-transmitted helminths in schoolchildren, Yunnan Province, China 0.65
Increased risk of antimicrobial resistance in patients with cirrhosis and hepatic encephalopathy using rifaximin 0.29
Differential gut transmission of IncP plasmid clades involving hypervirulent reveals plasmid-specific ecological adaptation 0.21
The rise and global spread of IMP carbapenemases (1996-2023): a genomic epidemiology study 0.83
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease 0.06
CD44 cross-linking promotes Plasmodium falciparum invasion 0.25
Remission spectroscopy resolves the mechanism of action of bedaquiline within living mycobacteria 0.07
High-resolution proteomics unveils salivary gland disruption and saliva-hemolymph protein exchange in Plasmodium-infected mosquitoes 0.03
Basic reproduction number varies markedly between closely related pandemic clones 0.11
Sensitive near point-of-care detection of asymptomatic and submicroscopic Plasmodium falciparum infections in African endemic countries 0.01
Enhanced virulence and stress tolerance are signatures of epidemiologically successful 0.03
Ecological connectivity of genomic markers of antimicrobial resistance in Escherichia coli in Hong Kong 0.23
Microhaplotype deep sequencing assays to capture infection lineages 0.34
Synchronized seasonal excretion of multiple coronaviruses coincides with high rates of coinfection in immature bats 0.39
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2 0.03
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants 0.06
Variation and prognostic potential of the gut antibiotic resistome in the FINRISK 2002 cohort 0.12
Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4+ T cells in chronic chikungunya disease 0.06
Structure and assembly of the MmpL5/MmpS5 efflux transporter from Mycobacterium tuberculosis 0.09
Impact of dhps mutations on sulfadoxine-pyrimethamine protective efficacy and implications for malaria chemoprevention 0.10
2 0.17
Antibiotic use and gut microbiome composition links from individual-level prescription data of 14,979 individuals 0.08
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial 0.09
2 0.20
TMPRSS2-mediated coronavirus spike activation and inhibition 0.08
Integrated structural biology of the native malarial translation machinery and its inhibition by an antimalarial drug 0.13
1 0.11
Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection. 0.11
2 0.17
Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: A modelling study 0.13
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials 0.04
1 0.73
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum 0.73
2 0.81
Mapping Bacillus Calmette–Guérin vaccination coverage in Africa from 1990 to 2022: a novel spatiotemporal modelling study 0.69
Regional and type-specific variations in the global seasonality of human parainfluenza viruses and the influence of climatic factors: a systematic review and meta-analysis 0.12
1 0.05
Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial 0.05

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.